Top 30 Medical Device VC Funds in Denmark
A list of 30 VC funds that invest in Medical device startups based in Denmark. We rank investors based on the number of investments they made in Medical device companies from Denmark. We update this investor list every month.Top 30 Medical Device VC Funds in Denmark
Investor | Medical Device Denmark investments |
---|---|
PSV | 8 |
Seed Capital | 7 |
BioInnovation Institute | 6 |
Vaekstfonden | 6 |
Vaekstfonden | 5 |
Novo Holdings | 4 |
People Ventures | 4 |
VF Venture | 3 |
West Hill Capital | 2 |
Crista Galli Ventures | 2 |
KMD Venture | 1 |
GoBeyond | 1 |
Norgine Ventures | 1 |
EIT Health | 1 |
NOON Ventures | 1 |
Alumni Ventures | 1 |
Nina Capital | 1 |
Lauxera Capital Partners | 1 |
Novo Ventures | 1 |
Innovation Fund Denmark | 1 |
Digital Leaders Ventures | 1 |
Sunstone Life Science Ventures | 1 |
Verve Ventures | 1 |
Seventure Partners | 1 |
ATP | 1 |
Swisscanto Private Equity | 1 |
Ugly Duckling Ventures | 1 |
North-East Healthcare Investment | 1 |
Sofinnova Partners | 1 |
Chr. Augustinus Fabrikker | 1 |
PreSeed Ventures are the preferred travel companion for trailblazing founders when they set out on the journey of transforming startup dreams to successful businesses. Founded in 2000 they have an exceptional track record of spotting, fostering and financing tomorrow’s winners in syndication with top-tier investors locally and globally. As the namesuggests, PreSeed Ventures operates at the earliest stages, where founders need the professional, operational & systematic support of a VC, but the risks are still too high for most VCs in seed stages. Yet to the powerhouse of experts behind PreSeed Ventures, who have experience from hundreds of startup journey in the pre-seed stage, it is an opportunity to support and nurture the growth of promising startups on the rise, minimizing the time and risk to the next investment round.PreSeed Ventures has grown out of the technological research environment at Denmark’s Technical University, DTU. In 2020 they launch their first full blown commercial venture fund, yet continuing to be a subsidiary company to the university.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Funding Round
- Denmark, United States, United Kingdom
Portfolio highlights
- spektr — Explore spektr's tailored compliance automation solutions for KYB monitoring, AML compliance, risk management, and more. Try our no-code, customizable platform for free today!
- UltiHash — Data powers breakthroughs. UltiHash is the storage foundation to accelerate them: blazing fast, highly efficient, and built for sustainable long-term growth.
- Yacheng Network — Yacheng Network is a provider of information technology and software services that specializes in offering these services.
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more
Investment focus
- Software, Health Care, SaaS
- Seed, Funding Round, Series A
- Denmark, United States, United Kingdom
Portfolio highlights
- Flatpay — Flatpay's fair, flat-rate pricing simplifies payments & cuts costs. Benefit from our comprehensive solution & superior customer service. Join us now!
- Mesh Bio — Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. They translate clinical data and numbers into actionable insights that help patientsbetter manage their health, lifestyle and disease risks.
- Embla — Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Convertible Note, Pre-Seed, Debt Financing
- Denmark, Germany, Switzerland
Portfolio highlights
- NorFalk — NorFalk rethinks the way to produce surfactants: the active and stabilizing ingredients in household care and personal care consumer products.
- TriptoBIO — TriptoBIO is developing a platform for producing natural plant compounds that will support the health of our planet. Our goal is to create a future where everyone can benefit from the power of plants, without depleting natural resources. Our first compound will liberate the world from rat poison
- HHC Medical — HHC Medical is a health tech company developing targeted non-invasive drug delivery devices through electroporation to transfect a large number of cells. It was founded in 2019 and is headquartered in Hillerød, Denmark.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Funding Round, Pre-Seed
- Denmark, United States, United Kingdom
Portfolio highlights
- Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
- Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
- kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more
Investment focus
- Software, SaaS, Information Technology
- Seed, Funding Round, Pre-Seed
- Denmark, United States, Norway
Portfolio highlights
- Wedio — Buy & Rent professional film equipment from trusted creators near you. Buy & rent cameras, lenses, drones with Global Coverage. Explore
- Keepit — The Keepit Cloud is the most cost-effective solution on the market with 20+ years of experience. Learn more about our next-level data protection services
- kleen hub — Kleen hub is Denmark's first digital return system for reusable coffee cups and food packaging.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
People Ventures are your dreamcast team of co-founders, investors, executives, engineers, academics and industry experts.
Together with talented entrepreneurs — We shape fantastic businesses through operational and commercial execution.
Show more
Investment focus
- Health Care, Internet of Things, Software
- Seed, Pre-Seed, Series A
- Denmark, Sweden, United States
Portfolio highlights
- Uniify — Uniify is a no-code customer onboarding software that makes it fast, easy and secure for financial companies to onboard their customers. Save your business time and money, and build onboarding flows for your customers in minutes instead of months.
- proemial — Proemial is building an open platform that connects researchers to a larger and more diverse audience through personalized summaries of the latest research papers. The mission is to make it easy to read, discuss, understand and engage with recent discoveries, the researchers that produce them, and the companies that commercialize them.
- Version Lens — Meet your new Product Management Co-Pilot. Reduce overhead for your product team so you can focus on what truly matters, building outstanding products.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more
Investment focus
- Software, Biotechnology, SaaS
- Seed, Funding Round, Series A
- Denmark, United Kingdom, Iceland
Portfolio highlights
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
- Chromologics — Chromologics produce natural sustainable colors. Our flagship product is ChromoRed which performs better than existing natural, red colorants. ChromoRed is also applicable with vegan, kosher and halal diets.
- Onomondo — Onomondo is a global IoT network. Our IoT SIM and cloud platform future proof your devices with full data transparency, freedom to leave, and no third parties.
West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.
Show more
Investment focus
- Information Technology, Software, Health Care
- Seed, Funding Round, Series A
- United Kingdom, Denmark
Portfolio highlights
- Bioomix — Bioomix is a biotechnology company that develops all-natural microbial products that can help farmers achieve a higher and better yield. It was founded in 2021 and its headquarters is located in Odense, Denmark.
- ATLANT 3D Nanosystems — Micro and nanodevices are built and tested within days instead of months or years.
- Formalize — A Whistleblower Software system made for accountants and lawyers that have clients, the whistleblower software system helps businesses implement a compliant solution that is both secure and transparent. their products are reporting links, case management, partner account they have designed a journey that makes feel safe about the process. AWS ishandling the physical security of the infrastructure, whistleblower software takes the shared responsibility of security between our cloud infrastructure and application seriously.
Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.
Show more
Investment focus
- Health Care, Wellness, Medical
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Sweden
Portfolio highlights
- Jude — Hey, we're Jude. A healthcare start-up on a mission is to bring bladder care into the mainstream.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds Radiology — Collective Minds® is the new radiology workspace. A cloud-based service for collaboration, consultation and access to new digital tools and expertise. We are building the largest global network of collective and artificial intelligence, with humans and machines.
KMD Venture operates in strategic growth segments and creates and manages user driven innovation, ideas generation, and incubation in close collaboration with users, customers, and business units. KMD Venture's purpose is to invest in opportunities that would not be picked up by KMD's existing business units, but may have great strategicand financial impact for KMD and to create and execute an external partnership setup to develop an entrepreneurial and innovative environment that can have a positive influence on KMD's innovation capability.KMD Venture only invests in startups and contribute with pre-seed or seed funding and the investment must have a strategic fit with KMD. KMD Venture A/S is owned by KMD A/S.
Show more
Investment focus
- Information Technology, Education, Health Care
- Seed, Funding Round
- Denmark
Portfolio highlights
- Diplomasafe — Issue digital diplomas, badges, and certificates at the click of a button.
- Egoo.Health — Egoo. Take action, own your health.
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more
Investment focus
- Information Technology, Medical, Software
- Funding Round, Seed, Series A
- Switzerland, Germany, United Kingdom
Portfolio highlights
- LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
- AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
- Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US. Norgine Ventures is backed by Norgine, a fully integrated, private,European healthcare company with over 110 years of experience in the pharma space.Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic and medical device companies, at various stages of their life cycle, both in Europe and in the US.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Funding Round, Debt Financing, Series A
- France, United Kingdom, United States
Portfolio highlights
- ImaginAb — ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics.
- PathoQuest — PathoQuest provides biosafety assays based on next-generation sequencing (NGS) for biologics quality testing. GMP biotesting for biopharmaceuticals. Learn more.
- Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Grant, Pre-Seed, Seed
- United Kingdom, Spain, Ireland
Portfolio highlights
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Noon Ventures is a Copenhagen-based, early-stage venture investor established in 2020. We invest in proven transformative technologies with the potential to impact environmental or climate challenges.
Show more
Investment focus
- Electronics, Biotechnology, Semiconductor
- Seed
- Denmark
Portfolio highlights
- SpectroInlets — Our EC-MS differs from traditional solutions through exceptional sensitivity, unparalleled time response and fully integrated software
- Enduro Genetics — Bioproduction can be difficult to scale to large cultivation volumes while keeping titers high. By applying game-changing synthetic biology technology, Enduro Genetics empowers our partner companies to maximize performance of all cells cultivated from their production strains.
- Lotus Microsystems — Lotus Microsystems offers miniaturized highly integrated point of load power converters. The devices are engineered for portable electronics manufacturers ready for usage whenever tiny power supply units are needed. Our devices offer up to 72% reduction in footprint compared to existing solutions with higher efficiency and reliability. Our plug andplay solutions enable our customers to innovate their electronics without worrying about power supply units.
Alumni Ventures offers diversified venture portfolios to accredited investors into highly competitive deals that individuals typically do not have access to on their own.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- United States, United Kingdom, Canada
Portfolio highlights
- Kudos — Kudos is a retail company that offers natural disposable baby diapers with cotton liners. The company's chemical-free diapers are made of plant-based renewable materials, providing parents with natural diapers that suit babies' sensitive skin. It was founded by Amrita Saigal in 2019 and is headquartered in Boston, Massachusetts, USA.
- teachme.to — Teachme.to is a community of learners discovering lessons for everything.
- Savvy Wealth — Savvy is the next-generation wealth management firm that pairs world-class advisors with modern software to help clients achieve their financial goals.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
- CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
- MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
We are an independent, international, healthcare-focused asset management company. Led by entrepreneurial company builders and seasoned healthcare investors with experience across international markets, we invest in Healthcare growth capital and Healthcare public equities.
Show more
Investment focus
- Biotechnology, Medical Device, Computer
- Series A, Series C, Series D
- France, Sweden, Denmark
Portfolio highlights
- BioLamina — BioLamina offers laminin cell culture matrix, the only laminins that are the original, full length, human recombinant laminins on the market.
- Jiaozhiwu — Jiaozhiwu is a food-tech brand that specializes in the research and development of synthetic biology in functional food ingredients and nutritional health products.
- Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.Novo A/S was established in 1999 prior to the demerger of Novo NordiskA/S, where Novozymes A/S was established as a stand-alone publicly listed company. Novo's purpose and objectives are to manage the Foundation's financial assets and to ensure the Foundation sufficient dividends to cover its grant obligations for medical and scientific research etc. in Scandinavia.Novo A/S attains these objectives through:compliance with the rules and principles which are set out in the Articles of Association of the Novo Nordisk Foundation regarding exercise of the voting rights of A and B shares in Novo Nordisk A/S and Novozymes A/S, respectively, assurance that all companies in which the company has a material influence actively contribute to the development of the Novo Group and operate their business in accordance with the visions and values of the Novo Group, maintenance of a material influence on Novo Nordisk A/S and Novozymes A/S, and investment and financing business including placing of capital in companies and real property domestically and abroad.Novo’s overall investment strategy is thus to maintain ownership of Novo Nordisk’ and Novozymes’ shares at a level just above 25% and to invest dividends from these companies and other income in the life science area as well as in a broad portfolio of financial assets.Novo A/S has since 1999 established itself as an international venture capital partner in the life science area and has invested in over 50 companies in Denmark, Europe and North America. Through its financial investment activities Novo A/S seeks to spread the company’s total financial risk and at the same time to ensure a high return taking into consideration the chosen risk profile. In 2007 Novo A/S together with the Novo Nordisk Foundation established ‘Novo Seeds’. The new program (split into two sub-programs) is aimed at supporting early stage applied research in the life science area in Scandinavia. At the beginning of 2009 Novo A/S launched a new initiative, investing 'growth equity' into promising later stage/commercial stage life science companies. Novo A/S represents the interests of the Novo Nordisk Foundation through participation on the boards of the companies in the Novo Group.The companies in the Novo Group are members of a 'family of companies', independently managed, but sharing a set of common values as set out in the 'Charter for Companies in the Novo Group'. In the Charter these core values, commitments and management principles that companies in the Novo Group should live up to are described.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- United States, United Kingdom, Switzerland
Portfolio highlights
- INBRACE — Swift Health Systems is a stealth stage medical device company developing INBRACE: a revolutionary, easy to use, wide indication, personalized orthodontic system hidden behind the teeth. Our patented self-guiding technology uses light and continuous forces to gently correct your smile with less pain and fewer doctor visits. INBRACE is FDAregistered and a catalyst for disruption in orthodontics. INBRACE increases the number of people who will seek orthodontic treatment by addressing the top concerns for patients while driving practice growth for clinicians. Our platform leverages digital treatment planning, computer modeling, and direct digital manufacturing to create a scalable, patient customized solution that delivers the standard of care across the entire range of orthodontic cases.
- Theraxyte — Theraxyte is an innovative nano-drug developer. It focuses on the R&D and application of new nano-drugs, especially innovative drugs.
- Amolyt Pharma — We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more
Investment focus
- Software, SaaS, Information Technology
- Grant, Pre-Seed, Seed
- Denmark, United States
Portfolio highlights
- Artelize — Discover events, performers and works within classical music, opera, musical, ballet & dance and drama. 174248 events, and 59606 artists and creators.
- Tryp.com — There is always a reason to go! We use artificial intelligence to find the best travel deals at the lowest price. The algorithm compares and connects flights, trains, and buses to create the perfect multidestination trips with matching hotel offers.
- Curvature AI — Grow your revenue with discounts and special offers selected and optimized by AI.
Digital Leaders Ventures (DLV) is a European Venture Capital Fund based in Luxembourg. DLV is investing in tech companies disrupting industries on a global level. They focus on entrepreneurs from Europe who go global from day one, combining a scalable business model with high growth and large demand.
Show more
Investment focus
- Information Technology, Mobile, Internet
- Seed, Angel, Series A
- United States, Denmark, France
Portfolio highlights
- Revue — Revue is a developer of an editorial newsletter tool designed to build a direct relationship with the readers. Revue is for everyone that has passion through newsletters or a university graduate wanting to talk about their interests. more. Revue is based in The Netherlands and focuses on content curation.
- PayKey — The PayKey social banking and mobile P2P payment solution: A patent-pending mobile payment keyboard that seamlessly integrates with your banking application and lets users complete a transaction without leaving their social application.
- Cortrium — Cortrium is in the business of manufacturing wearable vital sign sensors and analytics. The company has acquired the CE-marking, class IIa, as a manufacturer of ECG devices including the quality management standard ISO 13485. Cortrium has the C3 Holter Monitor as the first product. Next steps are introducíng wearable sensor technologies acrossmultiple disease area and linking them with a sophisticated patient and physician facing software platform.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series B, Series A
- Denmark, Sweden, Switzerland
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more
Investment focus
- Health Care, Software, Biotechnology
- Series A, Seed, Series B
- Switzerland, Germany, France
Portfolio highlights
- Cubbit — Cubbit is secure encrypted cloud storage with a difference. A distributed cloud that is 100% private and green. Join the Swarm.
- Axelera AI — To accelerate computer vision in edge devices, we offer a powerful, energy-efficient, cost-effective, user-friendly AI hardware and software platform.
- Neustark ag — Neustark enables zero-emissions concrete by capturing concrete production emissions from the atmosphere and permanently converting them to limestone. This climate positive limestone replaces cement and sand which are major cost drivers for concrete production.
Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series A, Series B, Funding Round
- France, United States, Germany
Portfolio highlights
- Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
- Allozymes — Allozymes applies its proprietary platform technology to rapidly develop novel enzymes, revolutionizing the way that industries manufacture complex natural
- Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
ATP is a self-governing institution, established by the Folketing by law in 1964. ATP's Board of Directors consists of equal representatives of employers and employees and an independent chairman of the board.
The ATP Group has approx. 3,000 employees. ATP is headquartered in Hillerød, customer service centers in Frederikshavn, Holstebro,Haderslev, Vordingborg, Lillerød and Hillerød, as well as offices in Copenhagen, Allerød and New York.
Show more
Investment focus
- Health Care, Health Diagnostics, Software
- Funding Round, Series B
- Denmark
Portfolio highlights
- MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
- Visiopharm — Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Show more
Investment focus
- Health Care, Manufacturing, Robotics
- Series B, Series C, Funding Round
- Switzerland, Germany, Belgium
Portfolio highlights
- Fotokite — Specialized actively tethered UAS built for First Responders, providing immediate situational awareness of an emergency scene.
- Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
At Ugly Duckling Ventures, we make capital, know-how, and real-world application available to Nordic ventures at the seed & pre-seed stage. We are operational by nature and want to get in the grind as we excel at getting early-stage ventures ready for scale.
Show more
Investment focus
- Information Technology, Software, Social Media
- Seed, Funding Round
- Denmark
Portfolio highlights
- Juristic — Juristic is the world's most advanced legal visualising tool - and it can automate legal drafting too! Solve complex legal and financial matters in real time. We are developing next-generation tools for advisers.
- BeCause — BeCause makes your sustainability manageable. BeCause is the single source of truth for collecting, coordinating and communicating your sustainability data.
- Diplomasafe — Issue digital diplomas, badges, and certificates at the click of a button.
North-East is an ambitious, global family office helping our families live with wealth in a meaningful way from our offices in Denmark and Singapore.
Show more
Investment focus
- Therapeutics, Biotechnology, Medical Device
- Series A
- Denmark
Portfolio highlights
- Reapplix — Diabetic foot ulcers have a debilitating impact on patients. About 60% of all patients experience a wound that does not heal.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Chr. Augustinus Fabrikker operates as an investment management firm with a core focus on dedicated ownership of Danish businesses. Founded in 1750, Chr. Augustinus Fabrikker has a capital base of more than 30 billion, a significant player in the Danish business community. It is owned by the Augustinus Foundation, which is one of Denmark'slargest cultural foundations, and also makes significant contributions to research and social initiatives.
Show more
Investment focus
- Software, Audio, Consumer Goods
- Series B, Series A, Series C
- Denmark
Portfolio highlights
- Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
- Podimo — Podimoa is an open podcast platform that offers a subscription service for creators. Founded in 2019, Podimo is a podcast and short-form audio platform which offers personalized recommendations to listeners, while offering creators a share of revenue via premium subscriptions. Co-founded by Morten Strunge, Nikolaj Koppel, Andreas Sachse, EvaLægdsgaard, and Sverre Dueholm, Podimo is hoping to capitalize on the rise in consumption in podcasts.
- Lunar — Free account with positive interest. Keep your budget, save, and make your money grow with ease. Sign up from your mobile phone in minutes.
Investors by industry
Climate
Community
Gaming
Energy
FinTech
Impact
Biotech
Media (entertainment)
Hardware
Proptech
Marketplace
Artificial intelligence
Consumer
Health Care
EdTech
Sustainability
Agriculture (agtech)
Venture Capital
Photography
B2B
Infrastructure
Education
Food and Beverage
Payments
Video Games
Retail
Medical
Social Network
Wellness
Android
Social Media
Digital Media
Google
Mobile
Fashion
Franchise
Music
Sports
Facebook
Legal
eSports
Local
Construction
Email
Enterprise Software
Internet
Art
Finance
Manufacturing
Travel
Recruiting
Cannabis
Biotechnology
Fitness
Platforms
Hospitality
Mobile Advertising
Publishing
Medical Device
Automotive
Wine And Spirits
Crowdfunding
Social
CleanTech
Clean Energy
Transportation
Financial Services
Mobile Apps
InsurTech
Big Data
Enterprise
Web3
Beauty
Oil and Gas
Real Estate
Organic Food
Theatre
LGBT
Film
Life Science
Non Profit
Renewable Energy
Celebrity
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Cryptocurrency
Blockchain
Investors by country
South Korea
New Zealand
Germany
Ireland
United States
Australia
India
United Kingdom
Canada
Japan
Vietnam
Sri Lanka
China
Saudi Arabia
Middle East
Africa
Oceania
Asia
Europe
Indonesia
Singapore
Spain
Armenia
LATAM
Brazil
Qatar
South Africa
Georgia
Bahrain
Belize
Ethiopia
Bermuda
Chile
Costa Rica
France
Estonia
Ghana
Kenya
Denmark
Mexico
Morocco
Belarus
Kazakhstan
Czech Republic
Panama
Kuwait
Cayman Islands
Liberia
Ecuador
Malta
Jersey
Liechtenstein
Egypt
Norway
Croatia
Peru
Finland
Israel
Hong Kong
Malaysia
Mauritius
Lithuania
Algeria
Mali
Gibraltar
Philippines
Nicaragua
Cambodia
Lebanon
Faroe Islands
Myanmar
Greece
Italy
Portugal
Thailand
Slovenia
Serbia
Sierra Leone
Rwanda
Poland
San Marino
Zimbabwe
Turkey
Hungary
Seychelles
Tanzania
Sweden
Puerto Rico
Taiwan
Uruguay
Barbados
Belgium
Senegal
Venezuela
El Salvador
Zambia
Tunisia
Bulgaria
Uzbekistan
Uganda
Russian Federation
Togo
Ukraine
Tajikistan
Dominican Republic
Azerbaijan
Bahamas
United Arab Emirates
Nigeria
Honduras
Namibia
Iraq
Iceland
Bolivia
Isle of Man
Luxembourg
Bangladesh
Pakistan
Albania
Argentina
Romania
Jordan
Grenada
Oman
Cyprus
Latvia
Austria
Switzerland
Cameroon
Colombia
Guatemala
Marshall Islands
VC Funds in Denmark by industry
Restaurants
Financial Services
Media (entertainment)
Big Data
Education
Finance
Payments
Food and Beverage
Video Games
Medical
Medical Device
Fitness
Transportation
Social Media
Internet
Manufacturing
Renewable Energy
Mobile
Blockchain
Software
eSports
Sports
Travel
Biotechnology
Hospitality
Enterprise
FinTech
Consumer
Health Care
Biotech
EdTech
Sustainability
Climate
Energy
Impact
Proptech
SaaS
Artificial intelligence
Agriculture (agtech)
Mobile Apps
Community
Hardware
Beauty
Retail
Fashion
Web3
B2B
Cryptocurrency
Recruiting
Real Estate
Marketplace
Life Science
Legal
Gaming
Wellness
CleanTech
Music
Enterprise Software
Automotive